Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2012-04-20 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LAON (02000), Aisne
PHARMACIE DE LA CITE : revenue, balance sheet and financial ratios
PHARMACIE DE LA CITE is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LAON (02000),
this company of category PME
shows in 2018 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA CITE (SIREN 751183674)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 527 016 €
2 275 056 €
Net income
185 220 €
213 408 €
239 782 €
264 675 €
229 579 €
196 531 €
219 266 €
191 691 €
163 976 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
310 364 €
293 490 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
7.6%
7.2%
Revenue and income statement
In 2025, PHARMACIE DE LA CITE generates positive net income of 185 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 164 k€ -> 185 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
185 220 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
53.154%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.884%
Solvency indicators evolution PHARMACIE DE LA CITE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
130.673
79.36
53.244
37.869
25.15
14.525
10.324
0.292
53.154
Financial autonomy
38.344
48.308
55.214
59.128
64.871
69.99
75.113
79.909
52.884
Repayment capacity
5.894
3.409
None
None
None
None
None
None
None
Cash flow / Revenue
7.219%
8.59%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
53.152025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+26 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA CITE (53.15) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.88%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-26 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA CITE (52.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA CITE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
113 434 €
120 311 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
26
26
0
0
0
0
0
0
0
Customer payment term (days)
5
6
0
0
0
0
0
0
0
Supplier payment term (days)
24
25
0
0
0
0
0
0
0
Positioning of PHARMACIE DE LA CITE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA CITE is estimated at
2 942 241 €
(range 1 996 619€ - 4 616 782€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1996k€2942k€4616k€
2 942 241 €Range: 1 996 619€ - 4 616 782€
NAF 5 année 2025
Valuation method used
Net Income Multiple
185 220 €
×
15.9x
=2 942 242 €
Range: 1 996 619€ - 4 616 782€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA CITE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA CITE
What is the revenue of PHARMACIE DE LA CITE ?
The revenue of PHARMACIE DE LA CITE in 2018 is 2.5 M€.
Is PHARMACIE DE LA CITE profitable?
Yes, PHARMACIE DE LA CITE generated a net profit of 185 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA CITE ?
The headquarters of PHARMACIE DE LA CITE is located in LAON (02000), in the department Aisne.
Where to find the tax return of PHARMACIE DE LA CITE ?
The tax return of PHARMACIE DE LA CITE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA CITE operate?
PHARMACIE DE LA CITE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart